TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma

Individual mutations in the tumor suppressor TP53 alter p53 protein function. Some mutations create a non-functional protein, whereas others confer oncogenic activity, which we term ‘oncomorphic’. Since mutations in TP53 occur in nearly all ovarian tumors, the objective of this study was to determin...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Oncol
Asıl Yazarlar: BRACHOVA, PAVLA, MUETING, SAMUEL R., CARLSON, MATTHEW J., GOODHEART, MICHAEL J., BUTTON, ANNA M., MOTT, SARAH L., DAI, DONGHAI, THIEL, KRISTINA W., DEVOR, ERIC J., LESLIE, KIMBERLY K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2014
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4277253/
https://ncbi.nlm.nih.gov/pubmed/25385265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2014.2747
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller